AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 118.50
+2.00 (1.72%)
Oct 20, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 11.56 billion as of October 20, 2026. It is the 17,047th most valuable company in the world and the 664th biggest in Taiwan. Its market cap has increased by 33.78% in one year.
Market Cap
11.56B
Enterprise Value
9.42B
Revenue
n/a
Global Rank
Country Rank
#664 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 11.56B, an increase of 126.81%. That is a compound annual growth rate of 28.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 11.56B | -24.56% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 16.77B |
| Medigen Vaccine Biologics | 16.77B |
| Ever Supreme Bio Technology | 15.41B |
| EirGenix | 14.66B |
| Gongwin Biopharm Holdings | 13.93B |
| ACRO Biomedical | 13.40B |
| Lumosa Therapeutics | 11.96B |
| TCM Biotech International | 9.43B |